Low-to-moderate dose glucocorticoids in primary Sjögren's syndrome patients on hydroxychloroquine/iguratimod therapy: a target trial emulation study.
To evaluate whether low-to-moderate dose glucocorticoids provide additional benefit in primary Sjögren's syndrome patients treated with hydroxychloroquine and/or iguratimod. Using the Chinese Rheumatism Data Center database, we emulated a pragmatic trial including 395 patie…